Search Results - "REITER, Yoram"

Refine Results
  1. 1

    Functional Specializations of Human Epidermal Langerhans Cells and CD14 + Dermal Dendritic Cells by Klechevsky, Eynav, Morita, Rimpei, Liu, Maochang, Cao, Yanying, Coquery, Sebastien, Thompson-Snipes, LuAnn, Briere, Francine, Chaussabel, Damien, Zurawski, Gerard, Palucka, A. Karolina, Reiter, Yoram, Banchereau, Jacques, Ueno, Hideki

    Published in Immunity (Cambridge, Mass.) (19-09-2008)
    “…Little is known about the functional differences between the human skin myeloid dendritic cell (DC) subsets, epidermal CD207 + Langerhans cells (LCs) and…”
    Get full text
    Journal Article
  2. 2
  3. 3

    The Intracellular Proteome as a Source for Novel Targets in CAR-T and T-Cell Engagers-Based Immunotherapy by Arman, Inbar, Haus-Cohen, Maya, Reiter, Yoram

    Published in Cells (Basel, Switzerland) (21-12-2022)
    “…The impressive clinical success of cancer immunotherapy has motivated the continued search for new targets that may serve to guide potent effector functions in…”
    Get full text
    Journal Article
  4. 4
  5. 5

    SS1P Immunotoxin Induces Markers of Immunogenic Cell Death and Enhances the Effect of the CTLA-4 Blockade in AE17M Mouse Mesothelioma Tumors by Leshem, Yasmin, King, Emily M, Mazor, Ronit, Reiter, Yoram, Pastan, Ira

    Published in Toxins (14-11-2018)
    “…SS1P is an anti-mesothelin immunotoxin composed of a targeting antibody fragment genetically fused to a truncated fragment of Pseudomonas exotoxin A. Delayed…”
    Get full text
    Journal Article
  6. 6

    HLA-DRα1 constructs block CD74 expression and MIF effects in experimental autoimmune encephalomyelitis by Meza-Romero, Roberto, Benedek, Gil, Yu, Xiaolin, Mooney, Jeffery L, Dahan, Rony, Duvshani, Nerri, Bucala, Richard, Offner, Halina, Reiter, Yoram, Burrows, Gregory G, Vandenbark, Arthur A

    Published in The Journal of immunology (1950) (01-05-2014)
    “…CD74, the cell-surface form of the MHC class II invariant chain, is a key inflammatory factor that is involved in various immune-mediated diseases as part of…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    T-Cell Receptor-Like Antibodies: Targeting the Intracellular Proteome Therapeutic Potential and Clinical Applications by Cohen, Maya, Reiter, Yoram

    Published in Antibodies (Basel) (01-09-2013)
    “…Major histocompatibility complex (MHC) class I molecules are key in the immune response against malignant cells by shaping the T-cell repertoire and presenting…”
    Get full text
    Journal Article Book Review
  10. 10

    Cutting Edge: MHC Class I-Ly49 Interaction Regulates Neuronal Function by Zohar, Ofer, Reiter, Yoram, Bennink, Jack R, Lev, Avital, Cavallaro, Sebastiano, Paratore, Sabrina, Pick, Chaim G, Brooker, Gary, Yewdell, Jonathan W

    Published in The Journal of immunology (1950) (15-05-2008)
    “…MHC class I molecules (MHC-I) have been implicated in nervous system development in the mouse. In this study we present evidence for the interaction of MHC-I…”
    Get full text
    Journal Article
  11. 11

    Antibodies and their fragments as anti-cancer agents by Schaedel, Oren, Reiter, Yoram

    Published in Current pharmaceutical design (2006)
    “…The recent developments in the field of recombinant DNA, protein engineering and cancer biology, have let us gain insight into many cancer-related mechanisms…”
    Get more information
    Journal Article
  12. 12

    Recombinant immunotoxins in targeted cancer cell therapy by Reiter, Yoram

    Published in Advances in Cancer Research (2001)
    “…Targeted cancer therapy in general and immunotherapy in particular combines rational drug design with the progress in understanding cancer biology. This…”
    Get full text
    Book Chapter Journal Article
  13. 13

    Antibody Molecules Discriminate between Crystalline Facets of a Gallium Arsenide Semiconductor by Artzy Schnirman, Arbel, Zahavi, Efrat, Yeger, Hadas, Rosenfeld, Ronit, Benhar, Itai, Reiter, Yoram, Sivan, Uri

    Published in Nano letters (01-09-2006)
    “…Seamless integration of biomolecules with manmade materials will most likely rely on molecular recognition and specific binding. In the following we show that…”
    Get full text
    Journal Article
  14. 14

    The influence of a human embryonic stem cell-derived microenvironment on targeting of human solid tumor xenografts by TZUKERMAN, Maty, ROSENBERG, Tzur, REITER, Irena, BEN-ELIEZER, Shoshana, DENKBERG, Galit, COLEMAN, Raymond, REITER, Yoram, SKORECKI, Karl

    Published in Cancer research (Chicago, Ill.) (01-04-2006)
    “…The awareness of the important role that the surrounding tissue microenvironment and stromal response play in the process of tumorigenesis has grown as a…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Efficiency of peptide presentation by dendritic cells compared with other cell types: implications for cross-priming by Zehn, Dietmar, Cohen, Cyril J., Reiter, Yoram, Walden, Peter

    Published in International immunology (01-12-2006)
    “…Dendritic cells (DCs) play a key role in the induction of cellular immune responses by harvesting antigens from peripheral tissue for cross-priming CD8+ T…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Predicting and controlling the reactivity of immune cell populations against cancer by Eden, Eran, Kubi, Adva, Schachter, Jacob, Akerman, Martin, Schallmach, Ester, Mandel-Gutfreund, Yael, Oved, Kfir, Alon, Uri, Izhaki, Orit, Wolchinsky, Ron, Reiter, Yoram, Noy, Roy, Zabari, Naama, Besser, Michal J

    Published in Molecular systems biology (28-04-2009)
    “…Heterogeneous cell populations form an interconnected network that determine their collective output. One example of such a heterogeneous immune population is…”
    Get full text
    Journal Article
  19. 19

    Tumor-Specific Ab-Mediated Targeting of MHC-Peptide Complexes Induces Regression of Human Tumor Xenografts in Vivo by Lev, Avital, Noy, Roy, Oved, Kfir, Novak, Hila, Segal, Dina, Walden, Peter, Zehn, Dietmar, Reiter, Yoram, Old, Lloyd J.

    “…A cancer immunotherapy strategy is described herein that combines the advantage of the well established tumor targeting capabilities of high-affinity…”
    Get full text
    Journal Article
  20. 20

    Vascular endothelial cells have impaired capacity to present immunodominant, antigenic peptides: a mechanism of cell type-specific immune escape by Kummer, Marco, Lev, Avital, Reiter, Yoram, Biedermann, Barbara C

    Published in The Journal of immunology (1950) (15-02-2005)
    “…Vascular endothelial cells (EC) are an exposed target tissue in the course of CTL-mediated alloimmune diseases such as graft-vs-host disease (GVHD) or solid…”
    Get full text
    Journal Article